IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Celladon Corp. & Advises Sharehol...
July 06 2015 - 9:16PM
Business Wire
Goldberg Law PC (www.Goldberglawpc.com) announces that a class
action lawsuit has been filed in the United States District Court
for the Southern District of California against Celladon
Corporation (“Celladon” or the “Company”) (NASDAQ: CLDN), for
alleged violations of the federal securities laws. Investors who
purchased or otherwise acquired shares between July 7, 2014 and
June 25, 2015, inclusive (the “Class Period”), have until August
31, 2015 to serve as lead plaintiff in the class action. In
addition, investors who purchased shares traceable to the Company’s
Initial Public Offering (“IPO”) on January 30, 2014, should contact
the firm to discuss this action.
If you are a shareholder who suffered a loss during the Class
Period, we advise you to contact Michael Goldberg or Brian Schall,
of Goldberg Law PC, 13650 Marina Pointe Dr. Suite 1404, Marina Del
Rey, CA 90292, at 800-977-7401, to discuss your rights without cost
to you. You can also reach us through the firm’s website at
http://www.Goldberglawpc.com, or by email at
info@goldberglawpc.com.
The class in this case has not yet been certified, and until
certification occurs, you are not represented by an attorney. If
you choose to take no action, you can remain an absent class
member.
Celladon is a biotechnology company focused on developing gene
therapies for cardiovascular diseases. The complaint alleges that
the Company made false and/or misleading statements and failed to
disclose adverse information regarding MYDICAR, its lead drug
candidate for the treatment of enzyme deficiency in patients
experiencing heart failure. On April 26, 2015, the Company reported
that its Phase 2b CUPID2 trial of MYDICAR did not meet its primary
and secondary goals. The Company had omitted to mention that the
CUPID1 trial was significantly smaller, and that success from the
first trial was not indicative of any success in the CUPID2 trial.
When the truth was revealed, the stock dropped causing damage to
investors.
If you have any questions concerning your legal rights in this
case, please immediately contact Goldberg Law PC at 800-977-7401,
or visit our website at http://www.Goldberglawpc.com, or email us
at info@goldberglawpc.com.
Goldberg Law PC represents shareholders around the world and
specializes in securities class actions and shareholder rights
litigation.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150706005883/en/
Goldberg Law PC, Los AngelesMichael Goldberg, Esq.
800-977-7401Brian Schall, Esq.
800-977-7401info@goldberglawpc.comhttp://www.Goldberglawpc.comhttps://twitter.com/goldberglawpchttps://www.facebook.com/pages/Goldberg-Law-PC/850505465033804?fref=ts
CELLADON CORP (NASDAQ:CLDN)
Historical Stock Chart
From Aug 2024 to Sep 2024
CELLADON CORP (NASDAQ:CLDN)
Historical Stock Chart
From Sep 2023 to Sep 2024